Accepted answer
3 mL of solution, and the rest depends on your dose. A 20 mg vial reconstituted to 6.67 mg/mL occupies 20 ÷ 6.67 = 3 mL. At a 1 mg weekly dose that is 20 weeks; at 2.4 mg weekly it is 8 weeks — and both of those assume the vial contains its label claim, which is the assumption a content assay exists to test. Subtract one draw's dead space per dose: a few microlitres on a fixed-needle syringe, up to a hundred on a luer one.
Write the units at every step, because units errors are the failure mode that catches everyone eventually.
Breaking it down further: if a 10 mg vial has 96.5 per cent content, you have 9.65 mg of peptide. Divide that by 2.00 mL and your concentration is 4.825 mg/mL, not 5.00 mg/mL, which is a 3.5 per cent systematic error in every dose calculation.
Concretely, air bubbles at these volumes are a measurement problem rather than a safety one. A 2 mm bubble in a 0.3 mL syringe is roughly 4 µL, which at 10 units drawn is a four per cent error.
Published data on syringe dead space quantifies low-dead-space designs as retaining under 2 µL against 35 µL or more for conventional detachable-needle syringes.
I would flag the obvious failure mode: people get the concentration right, get the volume right, and then read the syringe against the wrong scale.
If in doubt, use more diluent and accept the shorter usable window.
5The dead-space number surprised me until I did the multiplication across twenty draws. – kirsi_lahtinen 7 months ago 4Worth flagging that the U-40 syringes still exist and this arithmetic does not apply to them. – tri_gly_ala 5 months ago add a comment